Tetrabenazine - Neuromuscular disorders- (March 1999)
Drug Name:
Tetrabenazine - Neuromuscular disorders- (March 1999)
List Of Brands:
Indication Type Description:
Drug Interaction:
Tetrabenzine should not be given with or within 14 days of discontinuation of MAOI therapy. Blocks action of reserpine
Decreases effects of levodopa or worsens parkinsonism. Increased risk of extrapyrimidal side effects when given with amantadine, metoclopromide, Antipsychotics
Indication:
Movement disorders
New Drugs Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Tetrabenzene Presynaptic monoamime 10-03-1999
depleting agent
Adverse Reaction:
Drowsiness Extrapyrimidal symptoms, Parkinsonism, depression, Orthostatic hypotension GI disturbances Neuroleptic malignant syndrome NMS
Contra-Indications:
Lactation
Special precautions-
May exacerbate symptoms of parkinsonism Caution to be excercised when driving or performing skilled tasks Pregnancy
Dosages/ Overdosage Etc:
indication-
Movement disorders
Dosage-
Adult- initially 12.5mg bid, increased gradually to 12.5 to 25mg tid Max - 200mg daily. If no improvement at max. dose for 7 days, drug unlikely to be of benefit
Elderly- 12.5mg daily increased gradually Moderate to severe tardive dyskinesia
Adult- initially 12.5 mg increased gradually according to response.
Pregnancy and lactation:
Contraindicated for use during pregnancy and lactation Observe caution if required to be used